Septic Arthritis In Pediatrics

Disclaimer: This information is intended for educational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Clinical decisions must always be made by a qualified healthcare professional, taking into account the individual patient's circumstances and current medical evidence.

Overview

• Definition: Septic arthritis, also known as pyogenic arthritis or infectious arthritis, is a severe inflammatory condition characterized by the presence of bacteria or other microorganisms within a joint space, leading to an acute infection. It is a true orthopedic emergency in children, as delayed diagnosis and treatment can result in rapid and irreversible joint destruction, growth disturbances, and long-term disability.

• Epidemiology:

  • Incidence: Estimated incidence ranges from 5 to 12 cases per 100,000 children per year.
  • Age Distribution: Bimodal peak, most common in infants and young children (<3 years) and again in adolescents. Neonates are also at high risk.
  • Joint Involvement: The hip and knee are the most commonly affected joints, accounting for approximately 70-80% of cases. Other joints include the ankle, elbow, shoulder, and wrist. Multi-joint involvement is rare but can occur, especially in neonates or immunocompromised children.
  • Sex: A slight male predominance is often observed.

• Classification:

  • Acute Septic Arthritis: The most common form, characterized by rapid onset of symptoms over hours to days.
  • Chronic Septic Arthritis: Rare in children, usually associated with atypical organisms (e.g., mycobacteria, fungi) or delayed/inadequate treatment of acute infection.
  • Bacterial vs. Non-bacterial: While this document focuses on bacterial (septic) arthritis, it's important to differentiate from viral arthritis, fungal arthritis, or reactive arthritis.

Pathophysiology

• Mechanism:

  1. Hematogenous Seeding (Most Common): Bacteria from a distant primary infection (e.g., upper respiratory tract infection, otitis media, skin infection, urinary tract infection, bacteremia) enter the bloodstream and disseminate to the highly vascularized synovium.
  2. Direct Inoculation: Less common, resulting from penetrating trauma (e.g., puncture wound), joint injection, or surgery.
  3. Contiguous Spread: Rare, occurring from an adjacent osteomyelitis (bone infection) or cellulitis that extends into the joint space.
  4. Invasion and Inflammation: Once bacteria enter the synovial fluid, they proliferate rapidly. The host's immune response triggers a massive influx of polymorphonuclear leukocytes (PMNs) and release of inflammatory cytokines (e.g., TNF-α, IL-1, IL-6).
  5. Cartilage Destruction: Lysosomal enzymes released from neutrophils and bacterial proteases rapidly degrade articular cartilage, especially within the first few days of infection. Elevated intra-articular pressure due to pus accumulation can also compromise blood supply to the epiphysis, leading to avascular necrosis (particularly of the femoral head in hip septic arthritis).
  6. Bone Involvement: The infection can spread to the adjacent bone, causing osteomyelitis, especially in infants where the epiphyseal growth plate is still vascularized.

• Risk Factors:

  • Age: Neonates, infants, and young children (<3 years) due to immature immune systems and highly vascularized growth plates. Adolescents due to increased activity and potential for trauma or sexually transmitted infections (e.g., Neisseria gonorrhoeae).
  • Recent Infection: Upper respiratory tract infections, otitis media, pharyngitis, skin infections (impetigo, cellulitis), varicella.
  • Trauma: Minor trauma is often reported but may just draw attention to an already infected joint. Penetrating trauma is a direct risk.
  • Immunocompromise: Conditions like sickle cell disease, juvenile idiopathic arthritis (on immunosuppressants), diabetes mellitus, malignancy, primary immunodeficiency disorders.
  • Pre-existing Joint Disease: Juvenile idiopathic arthritis, hip dysplasia.
  • Indwelling Catheters or Lines: Central venous catheters can be a source of bacteremia.
  • Surgical Procedures: Recent orthopedic surgery.

• Protective Factors:

  • Intact Immune System: A healthy immune response can often clear bacteremia before joint seeding.
  • Prompt Treatment of Systemic Infections: Early and effective antibiotic treatment of primary infections may prevent hematogenous spread to joints.
  • Good Hygiene and Wound Care: Reduces the risk of skin infections that can lead to bacteremia.

Clinical Presentation

Signs and Symptoms

• Cardinal Features:

  • Pain: Severe, acute joint pain, often sudden in onset.
  • Refusal to Bear Weight/Move Limb: A hallmark sign, especially in the lower extremities (pseudoparalysis in infants). Children will often hold the affected limb in a position of comfort (e.g., hip in flexion, abduction, and external rotation to minimize intra-articular pressure).
  • Fever: Present in >80% of cases, but can be absent, especially in neonates or immunocompromised children.
  • Irritability: Especially in infants and toddlers who cannot verbalize pain.

• Early Signs:

  • Focal warmth, swelling, erythema over the affected joint.
  • Tenderness to palpation around the joint.
  • Restricted range of motion, particularly with passive movement, due to pain and muscle spasm.

• Advanced Signs:

  • Systemic signs of sepsis: Tachycardia, tachypnea, hypotension, lethargy, poor perfusion.
  • Severe joint swelling and deformity.
  • Progressive destruction of joint cartilage.

• Atypical Presentations:

  • Neonates: Often subtle, including poor feeding, irritability, minimal fever, decreased movement of an extremity (pseudoparalysis), or subtle swelling. Multiple joints can be affected.
  • Immunocompromised Children: May present with minimal inflammatory signs, absent fever, or less severe pain.
  • Afebrile Septic Arthritis: Occurs in up to 20-30% of cases, especially in younger children.
  • Concurrent Osteomyelitis: Can obscure the clinical picture.

Physical Examination

• Inspection:

  • Posture: Child may hold the affected limb in a specific position (e.g., hip in flexion, abduction, external rotation for septic hip).
  • Swelling: Visible effusion or soft tissue swelling around the joint.
  • Erythema: Redness of the overlying skin.
  • Muscle Spasm: Guarding of the joint.

• Palpation:

  • Warmth: Increased temperature over the joint.
  • Tenderness: Exquisite pain on gentle palpation.
  • Effusion: Palpable fluid accumulation, especially in superficial joints like the knee.

• Special Tests:

  • Passive Range of Motion (ROM): This is crucial. Passive ROM is severely limited and extremely painful in septic arthritis, contrasting with transient synovitis where pain is less severe and some passive ROM is preserved.
  • Kocher's Criteria (for septic hip in children): While not definitive, these criteria help risk stratify the likelihood of septic arthritis in a child with an irritable hip:
    1. Non-weight-bearing on the affected side.
    2. ESR > 40 mm/hr.
    3. Fever (oral temperature ≥ 38.5°C or 101.3°F).
    4. Serum white blood cell (WBC) count > 12,000 cells/mm³. * Interpretation:
       • 0 criteria: <1% chance of septic arthritis.
       • 1 criterion: 3% chance.
       • 2 criteria: 40% chance.
       • 3 criteria: 93% chance.
       • 4 criteria: 99% chance.
       • Note: These criteria are helpful for risk assessment but should not delay definitive diagnosis (joint aspiration).

Diagnostic Approach

History Taking

• Key Questions:

  • Onset and Duration: When did the pain start? Was it sudden or gradual? How long has the child been limping or refusing to move the limb?
  • Fever: Any fever, chills, or systemic symptoms?
  • Associated Symptoms: Recent skin infection, sore throat, ear infection, diarrhea, vomiting, rash, urinary symptoms?
  • Trauma: Any history of recent injury, even minor? Puncture wounds?
  • Prior Medical History: History of joint disease, sickle cell disease, immunodeficiency, recent hospitalizations, indwelling lines?
  • Vaccination Status: Up-to-date? (e.g., H. influenzae type b).
  • Travel History: Relevant for certain endemic pathogens.
  • Medications: Current medications, especially immunosuppressants.

• Red Flags:

  • Inability to bear weight.
  • Severe, rapidly worsening pain.
  • High fever.
  • Systemic signs of toxicity (lethargy, poor perfusion).
  • Limited and painful passive range of motion in the affected joint.

Laboratory Tests

• First-Line:

  • Complete Blood Count (CBC): Leukocytosis (>12,000 cells/mm³) with a left shift (increased neutrophils/bands) is common, but a normal WBC count does not rule out septic arthritis.
  • Erythrocyte Sedimentation Rate (ESR): Typically elevated (>20 mm/hr, often >40 mm/hr). It's a non-specific inflammatory marker but useful for monitoring response to treatment.
  • C-Reactive Protein (CRP): A more sensitive and rapid-responding acute phase reactant than ESR. Levels are usually elevated (>20 mg/L, often much higher) and normalize more quickly with effective treatment. CRP is often considered a stronger predictor than ESR.
  • Blood Cultures: Obtain before antibiotic administration. Positive in 30-50% of cases, providing definitive pathogen identification and antibiotic sensitivities. Collect at least two sets from different sites.
  • Procalcitonin (PCT): May be elevated in bacterial infections and can help differentiate bacterial from viral or inflammatory conditions. Levels >0.5 ng/mL are suggestive of bacterial infection, though specific cutoffs vary.

• Confirmatory:

  • Joint Aspiration (Arthrocentesis): This is the gold standard for diagnosis. It is an urgent procedure that should be performed as soon as septic arthritis is suspected, ideally by an orthopedic surgeon or an experienced radiologist under ultrasound guidance (especially for hip, shoulder).
    • Synovial Fluid Analysis:
      • Cell Count with Differential: Leukocytosis, typically >50,000 WBC/mm³, with a predominance of polymorphonuclear leukocytes (>75-90%). Counts can be lower in early infection or in immunocompromised patients.
      • Gram Stain: Positive in 30-50% of cases, providing rapid presumptive identification of the bacterial type (e.g., Gram-positive cocci in clusters suggests Staphylococcus aureus).
      • Culture and Sensitivity: Definitive identification of the causative organism and its antibiotic susceptibility. This is critical for guiding targeted therapy.
      • Glucose: Significantly lower than serum glucose (<40 mg/dL or <50% of serum glucose).
      • Protein: Elevated (>2.5 g/dL).
      • Lactate: Elevated (often >10 mmol/L).
      • Crystal Analysis: To rule out crystal-induced arthritis (e.g., gout, pseudogout), although rare in children.
      • Polymerase Chain Reaction (PCR): Especially useful for detecting Kingella kingae in young children, which can be difficult to grow in standard cultures. May also be used for Neisseria gonorrhoeae or other organisms.

• Monitoring:

  • Serial CRP and ESR: Monitor daily or every 2-3 days initially to assess response to treatment. A decreasing trend indicates effective therapy. CRP typically normalizes within 7-10 days, while ESR may take longer (weeks).
  • Clinical Assessment: Daily evaluation of pain, fever, joint swelling, and range of motion.

Imaging

• Recommended:

  • Plain Radiographs (X-rays):
    • Purpose: Primarily to rule out fracture, osteomyelitis, or underlying bone pathology. Early findings in septic arthritis are often subtle or non-existent.
    • Findings: May show joint space widening (due to effusion), soft tissue swelling, or subtle periarticular osteopenia (late). In hip septic arthritis, the affected femoral head may appear displaced laterally or inferiorly.
  • Ultrasound:
    • Purpose: Highly sensitive for detecting joint effusions, especially in the hip (where physical exam is limited). Also invaluable for guiding joint aspiration.
    • Findings: An anechoic or hypoechoic collection within the joint capsule. Comparison with the contralateral joint is often helpful. An effusion of >2-3 mm difference between hips is significant.

• Advanced:

  • Magnetic Resonance Imaging (MRI):
    • Purpose: Excellent for visualizing soft tissues, cartilage, and bone marrow. Crucial for differentiating septic arthritis from osteomyelitis, transient synovitis, or other conditions when the diagnosis is unclear or if there's concern for contiguous bone involvement.
    • Findings: Synovial enhancement, joint effusion, cartilage erosion, bone marrow edema, and periarticular soft tissue inflammation. Can identify early osteomyelitis.
  • Bone Scan (Technetium-99m Scintigraphy): Less specific than MRI but can identify areas of increased metabolic activity, useful for detecting multifocal osteomyelitis or when MRI is contraindicated. Not typically a first-line diagnostic for septic arthritis alone due to its lower specificity.

Management

Acute Management

• Immediate:

  • Emergency Orthopedic Consultation: Contact orthopedics as soon as septic arthritis is suspected.
  • Analgesia: Provide adequate pain control (e.g., IV opioids, NSAIDs) to ensure comfort and facilitate examination/procedures.
  • IV Access: Establish intravenous access for fluid administration and antibiotics.
  • Cultures: Obtain blood cultures before administering antibiotics.
  • Joint Aspiration: Perform emergent arthrocentesis for diagnostic fluid analysis and immediate decompression of the joint.

• Stabilization:

  • Fluid Resuscitation: If the child shows signs of hypovolemia or sepsis.
  • Empiric Intravenous Antibiotics: Initiate broad-spectrum antibiotics immediately after cultures are obtained, without waiting for synovial fluid culture results. The choice depends on the child's age, local epidemiology, and suspected pathogens (see "Treatment Algorithms" below).

• Emergency:

  • Joint Drainage (Surgical or Repeated Aspiration): The definitive acute treatment. The primary goal is to remove pus, decrease intra-articular pressure, and eliminate the bacterial load to prevent cartilage destruction.
    • Hip/Shoulder: Typically requires surgical drainage (open arthrotomy or arthroscopy) due to their deep location and the high risk of complications (e.g., avascular necrosis of the femoral head if pressure is not relieved).
    • Knee/Ankle/Elbow: Can often be managed with repeated needle aspirations (typically under ultrasound guidance) or arthroscopic drainage. Surgical drainage may be required if needle aspirations fail to adequately decompress the joint or if there's persistent infection.
  • Splinting: Immobilize the affected joint in a position of comfort to reduce pain and inflammation initially.

Chronic Management

• Pharmacological:

  • Antibiotic Therapy:
    • Duration: Typically 2-4 weeks, adjusted based on the pathogen, clinical response, and inflammatory markers (CRP/ESR). Some guidelines suggest 3-4 weeks for Gram-positive organisms and 4-6 weeks for Gram-negative organisms.
    • Route: Initial IV therapy (for at least 5-7 days or until significant clinical improvement and normalization of fever/inflammatory markers) followed by oral antibiotics. Transition to oral antibiotics is appropriate when the patient is afebrile, clinically improving, inflammatory markers are trending down, and they can tolerate oral intake.
    • Specific Agents: Guided by culture and sensitivity results. (See "Treatment Algorithms").

• Non-pharmacological:

  • Physical Therapy/Rehabilitation: Essential after the acute inflammatory phase. Once pain subsides and infection is controlled, active and passive range of motion exercises are crucial to prevent joint stiffness and restore function.
  • Immobilization: Brief period of splinting/traction may be used initially for pain relief, but prolonged immobilization should be avoided to prevent joint stiffness.

• Monitoring:

  • Clinical Assessment: Regular follow-up to monitor for residual pain, swelling, limited ROM, or signs of recurrence.
  • Inflammatory Markers: Serial CRP and ESR until they normalize.
  • Imaging: Follow-up X-rays to monitor for signs of cartilage damage, osteomyelitis, or avascular necrosis, especially in the hip. MRI may be indicated if there are concerns for complications or persistent symptoms.

Treatment Algorithms

• First-Line (Empiric IV Antibiotics after Cultures & Drainage):

  • Neonates (<1 month):
    • Common Pathogens: Staphylococcus aureus (including MRSA), Group B Streptococcus (GBS), Gram-negative bacilli (e.g., E. coli).
    • Antibiotics: Nafcillin/Oxacillin (or Vancomycin if MRSA risk) + Cefotaxime (or Gentamicin for Gram-negative coverage).
  • Infants and Young Children (1 month - 5 years):
    • Common Pathogens: Staphylococcus aureus (most common), Kingella kingae (increasingly recognized), Group A Streptococcus (GAS), Streptococcus pneumoniae.
    • Antibiotics: Cefazolin (or Nafcillin/Oxacillin) AND a third-generation cephalosporin (e.g., Ceftriaxone or Cefotaxime) to cover Kingella kingae and S. pneumoniae. Vancomycin if MRSA prevalence is high or suspected.
  • Older Children (>5 years):
    • Common Pathogens: Staphylococcus aureus (most common), Group A Streptococcus (GAS).
    • Antibiotics: Cefazolin (or Nafcillin/Oxacillin). Vancomycin if MRSA risk factors are present or local MRSA rates are high.
  • Adolescents (Sexually Active):
    • Common Pathogens: Neisseria gonorrhoeae, Staphylococcus aureus, GAS.
    • Antibiotics: Ceftriaxone (to cover N. gonorrhoeae) + an anti-staphylococcal agent (e.g., Cefazolin or Vancomycin). Screen for other STIs.
  • Special Circumstances:
    • Sickle Cell Disease: Consider Salmonella species. Empiric coverage should include a third-generation cephalosporin (e.g., Ceftriaxone or Cefotaxime).
    • Puncture Wound (foot): Consider Pseudomonas aeruginosa. Empiric coverage should include an anti-pseudomonal agent (e.g., Ceftazidime, Piperacillin-tazobactam, Cefepime).

• Second-Line (After Culture Results):

  • Tailored Therapy: Once culture and sensitivity results are available, narrow the antibiotic spectrum to the most effective agent.
  • Oral Transition: Transition from IV to oral antibiotics once the child is clinically stable, afebrile for 24-48 hours, inflammatory markers are declining, and there is clear evidence of clinical improvement. Ensure good oral bioavailability for the chosen antibiotic.

• Refractory Cases:

  • Re-evaluation: If there is no clinical improvement or worsening despite adequate drainage and antibiotic therapy (persistent fever, pain, elevated inflammatory markers):
    • Re-aspirate/Re-drain: Consider repeating joint aspiration or surgical drainage to ensure complete removal of pus.
    • Re-culture: Obtain new synovial fluid and blood cultures.
    • Imaging: Repeat imaging (e.g., MRI) to rule out osteomyelitis, abscess formation, or inadequate drainage.
    • Antibiotic Review: Reassess antibiotic choice, dose, and adherence. Consider resistant organisms or unusual pathogens.
    • Consult Infectious Disease: For complex or refractory cases.

Complications

• Common:

  • Joint Stiffness/Reduced Range of Motion: Due to fibrosis and capsular thickening.
  • Chronic Pain.

• Serious:

  • Avascular Necrosis (AVN): Particularly of the femoral head in hip septic arthritis, due to increased intra-articular pressure compromising blood supply.
  • Osteomyelitis: Infection spreading to the adjacent bone, often seen in up to 15-20% of cases, especially in hip septic arthritis or in younger children where epiphyseal vessels cross the physis.
  • Growth Plate Arrest/Deformity: Damage to the epiphyseal growth plate can lead to limb length discrepancy or angular deformities.
  • Pathologic Fracture: Weakening of bone due to infection can lead to fracture.
  • Sepsis/Septic Shock: Systemic inflammatory response to infection, potentially life-threatening.
  • Recurrence: If treatment is inadequate or underlying risk factors persist.

• Long-term:

  • Secondary Osteoarthritis: Due to irreversible cartilage damage.
  • Joint Subluxation/Dislocation: Can occur if supporting ligaments and capsule are damaged.
  • Need for Arthrodesis or Arthroplasty: In severe cases with extensive joint destruction.
  • Functional Impairment: Reduced quality of life due to chronic pain, limited mobility, and need for repeated surgeries.

Prognosis

• Factors:

  • Age at Onset: Younger children (especially neonates and infants) tend to have a poorer prognosis due to delayed diagnosis, atypical presentations, and higher risk of AVN and growth plate damage.
  • Joint Involved: Hip septic arthritis generally has the worst prognosis due to high risk of AVN and secondary osteoarthritis. Knee and other peripheral joints generally have better outcomes.
  • Pathogen Virulence: More aggressive organisms or resistant strains can lead to worse outcomes.
  • Duration of Symptoms Before Treatment: Delay in diagnosis and initiation of treatment significantly correlates with poorer outcomes and increased risk of joint damage. Treatment initiated within 4 days of symptom onset is associated with better outcomes.
  • Adequacy of Drainage: Complete and timely drainage is crucial for preventing long-term complications.

• Survival: Mortality is rare with modern medical care, but remains a risk in severe sepsis or in immunocompromised children.

• Quality of Life: Can be significantly impacted by chronic pain, limited joint function, need for bracing, physical therapy, or reconstructive surgeries. Up to 25-50% of children may experience some degree of long-term functional impairment or require further intervention.

Prevention

• Primary:

  • Vaccinations: Routine childhood immunizations (e.g., against H. influenzae type b, S. pneumoniae) have significantly reduced the incidence of septic arthritis caused by these pathogens.
  • Prompt Treatment of Bacterial Infections: Early and effective treatment of skin infections, otitis media, pharyngitis, and other bacterial infections may reduce the risk of bacteremia and subsequent joint seeding.

• Secondary:

  • High Index of Suspicion: Clinicians caring for children must maintain a high index of suspicion for septic arthritis in any child presenting with a limp, joint pain, or pseudoparalysis, especially with fever or elevated inflammatory markers.
  • Rapid Diagnosis and Intervention: The most critical aspect of secondary prevention is prompt diagnosis through joint aspiration and immediate initiation of appropriate surgical drainage and antibiotic therapy.

• Tertiary:

  • Aggressive Management of Complications: Early recognition and management of complications like AVN or osteomyelitis.
  • Rehabilitation: Comprehensive physical therapy and rehabilitation to restore joint function and prevent long-term stiffness.
  • Long-term Follow-up: Regular orthopedic follow-up to monitor for growth disturbances, secondary osteoarthritis, or need for reconstructive surgery.

Special Populations

• Pediatric: (This is the primary focus of the document, but highlights specific points)

  • Neonates: Subtle signs, often afebrile. May present with pseudoparalysis or decreased movement. Higher risk of multi-joint involvement and Gram-negative organisms (e.g., GBS, E. coli). High risk of AVN due to immature vascular supply.
  • Infants/Toddlers: Often unable to verbalize pain, presenting with irritability, refusal to bear weight, or pseudoparalysis. Kingella kingae is a common pathogen in this age group, requiring specific diagnostic approaches (e.g., PCR).
  • Children with Comorbidities:
    • Sickle Cell Disease: Increased risk of septic arthritis and osteomyelitis, often caused by Salmonella species or S. aureus. Differentiation from vaso-occlusive crisis can be challenging.
    • Immunocompromised: May have atypical presentations with less pronounced inflammatory signs or fever. Broader empiric antibiotic coverage may be needed.
    • Juvenile Idiopathic Arthritis (JIA): Septic arthritis can mimic a flare. Synovial fluid analysis is crucial for differentiation.

• Geriatric: Not applicable to this pediatric topic.

• Pregnancy: Not applicable to this pediatric topic.
• Comorbidities: Addressed under pediatric special considerations for conditions relevant to children.

Clinical Pearls

• Diagnostic:

  • "Limp with a Fever": Always raises suspicion for septic arthritis (or osteomyelitis). Do not dismiss a limp in a febrile child.
  • Kocher's Criteria: Useful for risk stratification of septic hip but do not replace the need for definitive diagnosis.
  • Joint Aspiration is King: Do not delay arthrocentesis for definitive diagnosis and treatment. Imaging (ultrasound) can guide the aspiration.
  • Painful Passive ROM: This is a critical distinguishing factor from conditions like transient synovitis, where passive motion is generally less painful and restricted.
  • Kingella kingae: Remember this pathogen in young children (6 months to 4 years), especially if Gram stain and routine cultures are negative but inflammatory markers are high. Request specific PCR testing if available.

• Treatment:

  • Surgical Emergency: Septic arthritis, especially of the hip, is an emergency requiring prompt orthopedic intervention for drainage.
  • Empiric Antibiotics: Start broad-spectrum IV antibiotics immediately after cultures are drawn. Do not delay for imaging or aspiration results once suspected.
  • Tailored Therapy: Narrow antibiotic spectrum based on culture and sensitivity results.
  • Early Mobilization: Once the acute phase of infection is controlled and pain subsides, early initiation of physical therapy is essential to prevent stiffness.

• Pitfalls:

  • Misdiagnosis as Transient Synovitis: The most common pitfall. Always differentiate based on severity of pain, ability to bear weight, and inflammatory markers. If doubt exists, aspirate.
  • Delay in Diagnosis and Treatment: Leads to irreversible joint destruction.
  • Inadequate Drainage: Failure to completely drain pus, especially from the hip, can lead to persistent infection and complications.
  • Insufficient Antibiotic Duration: Leading to relapse or chronic infection.
  • Ignoring Atypical Presentations: Especially in neonates or immunocompromised children.
  • Administering Antibiotics Before Cultures: This can hinder pathogen identification.

Recent Updates

• Guidelines: Current guidelines emphasize the critical importance of early diagnosis and intervention. Recommendations from organizations like the Infectious Diseases Society of America (IDSA), American Academy of Pediatrics (AAP), and pediatric orthopedic societies consistently stress the need for prompt joint aspiration, cultures, empiric broad-spectrum antibiotics, and urgent joint drainage.
• Evidence:
  • Increased Recognition of Kingella kingae: Molecular diagnostic techniques (PCR) have highlighted K. kingae as a significant pathogen in septic arthritis and osteomyelitis in young children (6 months to 4 years old), often presenting with milder inflammatory markers and a higher rate of negative cultures.
  • Role of Procalcitonin: Increasing evidence suggests procalcitonin may be a useful biomarker to help differentiate bacterial from non-bacterial causes of joint inflammation and for monitoring treatment response.
  • Debate on Surgical vs. Non-Surgical Drainage: While surgical drainage remains standard for hip and shoulder, the optimal approach for knee septic arthritis (arthroscopy vs. repeated needle aspiration) continues to be debated, with evidence supporting both for certain cases.
• Controversies:
  • Optimal Duration of Antibiotic Therapy: While 2-4 weeks is generally accepted, precise duration based on pathogen, age, and clinical response is still an area of ongoing research.
  • Transition from IV to Oral Antibiotics: Criteria for safe transition from intravenous to oral antibiotics are becoming more refined, focusing on clinical improvement and trending inflammatory markers, but optimal timing varies.
  • Utility of Repeat Imaging: The role and timing of repeat imaging (e.g., MRI) in asymptomatic children or those with uncomplicated resolution remain under discussion.

Key References

• Guidelines:

  • Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection (though not specific to SA, principles of bacteremia management are relevant).
  • American Academy of Pediatrics (AAP) Red Book: Report of the Committee on Infectious Diseases.
  • Various pediatric orthopedic society guidelines (e.g., Pediatric Orthopaedic Society of North America - POSNA position statements).

• Studies:

  • Landmark studies on Kocher's criteria for septic hip diagnosis.
  • Studies evaluating the role of PCR for Kingella kingae in pediatric osteoarticular infections.
  • Retrospective and prospective cohort studies on outcomes of pediatric septic arthritis.

• Reviews:

  • Comprehensive reviews in pediatric infectious diseases and orthopedic journals focusing on diagnosis and management of septic arthritis in children.
  • UpToDate, DynaMed, and other evidence-based clinical reference tools.